NCT01535560View on ClinicalTrials.gov

Safety and Efficacy Evaluation of Topical AL-60371 Otic Suspension, 0.3% in the Treatment of Acute Otitis Externa

PHASE3CompletedINTERVENTIONAL

Enrollment

589

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions

Acute Otitis Externa

Interventions

DRUG

AL-60371, 0.3% otic suspension

Investigational otic suspension intended for the treatment of acute otitis externa

DRUG

AL-60371 Vehicle

Inactive ingredients used as placebo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Alcon Research

INDUSTRY